News & Events

Highlighting the Progress, Discoveries of Curogen

Upcoming Events
Sep 11, 2025
CUROGEN at Morgan Stanley Global Healthcare Conference 2025

 



CUROGEN participated in the 23rd Annual Morgan Stanley Global Healthcare Conference, held September 8-10, 2025 in New York.

During the event, our CEO Chang-Woo Lee and our business development division leader Angela Lee met with global healthcare investors to share recent progress in both our novel small-molecule and multi-specific biologics platforms for autoimmune diseases. We also highlighted our near-term clinical milestones and strategic priorities in business development.

The conference provided a valuable opportunity to connect with investors and big pharmas and reinforce our commitment to developing transformative therapies for autoimmune and inflammatory diseases.